Development of an in vitro extracellular matrix assay for studies of brain tumor cell invasion
- PMID: 7807179
- DOI: 10.1007/BF01057956
Development of an in vitro extracellular matrix assay for studies of brain tumor cell invasion
Abstract
Invasion of brain by tumor cells is an inherent feature of the malignant phenotype. Assays to quantitate invasiveness should provide a powerful tool to investigate this phenomenon. We have developed a modified in vitro assay to measure tumor cell invasion, attachment, and chemotaxis using a barrier of the complex basement membrane Matrigel on gelatin-coated filters. Within 5 hours, 7.8% of U251MGp and 2.6% of SF126 human malignant glioma cells invaded the Matrigel and filter, compared with 0.8% of normal human leptomeningeal cells. The extent of invasion was directly proportional to incubation time and filter pore size and inversely proportional to the Matrigel concentration. Cells from exponentially growing U251MGp cultures invaded more readily (10.9%) than cells from plateau-phase cultures (2.3%); however, labeling studies with bromodeoxyuridine showed that quiescent cells and rapidly dividing cells were equally capable of invading. This suggests that the mechanisms underlying invasion by malignant glioma cells are distinct from those underlying proliferation and indicates the need for therapy aimed specifically at invasive behavior. In a practical application of this assay to test a potential anti-invasive strategy, monoclonal antibodies to the beta subunit of an integrin receptor mediating attachment to the extracellular matrix inhibited invasion by U251MGp cells in a dose-dependent manner. This assay should allow evaluation of the cellular and molecular basis of brain tumor progression and perhaps aid the development of rationally designed drugs that limit tumor invasion. It may also allow prediction of the clinical behavior of neoplasms in individual patients.
Similar articles
-
Basement membrane invasion of glioma cells mediated by integrin receptors.J Neurosurg. 1994 Mar;80(3):515-9. doi: 10.3171/jns.1994.80.3.0515. J Neurosurg. 1994. PMID: 8113864
-
Tetraarsenic oxide-induced inhibition of malignant glioma cell invasion in vitro via a decrease in matrix metalloproteinase secretion and protein kinase B phosphorylation.J Neurosurg. 2014 Dec;121(6):1483-91. doi: 10.3171/2014.8.JNS131991. Epub 2014 Oct 10. J Neurosurg. 2014. PMID: 25303017
-
Stimulation of extracellular matrix components in the normal brain by invading glioma cells.Int J Cancer. 1998 Mar 16;75(6):864-72. doi: 10.1002/(sici)1097-0215(19980316)75:6<864::aid-ijc8>3.0.co;2-t. Int J Cancer. 1998. PMID: 9506531
-
Role of plasminogen activator and of 92-KDa type IV collagenase in glioblastoma invasion using an in vitro matrigel model.J Neurooncol. 1994;18(2):129-38. doi: 10.1007/BF01050419. J Neurooncol. 1994. PMID: 7964975 Review.
-
Interactions of glioma cells and extracellular matrix.J Neurooncol. 1995;24(1):87-91. doi: 10.1007/BF01052664. J Neurooncol. 1995. PMID: 8523081 Review.
Cited by
-
Micron-scale positioning of features influences the rate of polymorphonuclear leukocyte migration.Biophys J. 2001 Nov;81(5):2569-79. doi: 10.1016/S0006-3495(01)75901-2. Biophys J. 2001. PMID: 11606271 Free PMC article.
-
Toward 3D biomimetic models to understand the behavior of glioblastoma multiforme cells.Tissue Eng Part B Rev. 2014 Aug;20(4):314-27. doi: 10.1089/ten.TEB.2013.0227. Epub 2013 Oct 30. Tissue Eng Part B Rev. 2014. PMID: 24044776 Free PMC article. Review.
-
Matrix metalloproteinase-9 and -2 and tissue inhibitor of matrix metalloproteinase-2 in invasive pituitary adenomas: A systematic review and meta-analysis of case-control trials.Medicine (Baltimore). 2016 Jun;95(24):e3904. doi: 10.1097/MD.0000000000003904. Medicine (Baltimore). 2016. PMID: 27310993 Free PMC article. Review.
-
Inhibitory effects of CAI in glioblastoma growth and invasion.J Neurooncol. 1997 Apr;32(2):93-101. doi: 10.1023/a:1005777711567. J Neurooncol. 1997. PMID: 9120549
-
Matrix metalloproteinase-9, a potential biological marker in invasive pituitary adenomas.Pituitary. 2008;11(1):37-48. doi: 10.1007/s11102-007-0066-2. Pituitary. 2008. PMID: 17768685
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Medical